Physician profile

Robert L Thomas

Internal Medicine · Walterboro, SC

NPI 1750351508

$13,156.43

in general payments reported to CMS, 2019-2025

47 companies · $1,364 in 2025

The $1,364 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,848.66
Education$232.45

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $1,835.59 2019-2025 Airsupra, Breztri, Farxiga
Jazz Pharmaceuticals INC. $1,297.54 2019-2024 Xywav
Glaxosmithkline, LLC. $1,181.76 2019-2025 Trelegy Ellipta, Nucala
Insmed, INC. $1,156.82 2019-2025 Arikayce, Brinsupri
Janssen Pharmaceuticals, INC $949.06 2019-2022
Grifols USA, LLC $874.97 2019-2025 Prolastin-C Liquid, Xembify
Boehringer Ingelheim Pharmaceuticals, INC. $833.51 2019-2025 Ofev, Jascayd
Genzyme Corporation $591.99 2022-2025
Axsome Therapeutics, INC. $530.06 2022-2025 Sunosi
Mallinckrodt Hospital Products INC. $352.36 2021-2025 Acthar
Harmony Biosciences LLC $335.25 2020-2024 Wakix
Baxter Healthcare $248.61 2022-2024 Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System
Mylan Specialty L.P. $222.39 2019-2024 Yupelri
Philips North America LLC $216.18 2019-2024 (Ak6) Vest Therapy
Avadel Cns Pharmaceuticals, LLC $203.82 2024-2025 Lumryz
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $194.12 2020-2025 Glassia
Genentech USA, INC. $171.30 2019
Novartis Pharmaceuticals Corporation $156.24 2019-2022
Amgen INC. $147.96 2025 Tezspire
Bayer Healthcare Pharmaceuticals INC. $133.47 2022-2024
E.R. Squibb & Sons, L.L.C. $119.73 2020
Astellas Pharma US INC $117.86 2019
Lilly USA, LLC $110.83 2024-2025 Mounjaro, Zepbound
Pfizer INC. $109.37 2019-2024
Sunovion Pharmaceuticals INC. $90.70 2019-2020
Amarin Pharma, INC. $85.56 2019-2022
Verona Pharma, INC. $85.45 2025 Ohtuvayre
Boston Scientific Corporation $83.80 2019
Exact Sciences Corporation $79.40 2024 Cologuard Collection Kit
Ani Pharmaceuticals, INC. $71.60 2024-2025 Purified Cortrophin Gel
Averitas Pharma INC. $68.82 2025 Qutenza
Shire North American Group INC $66.75 2019
Abbvie INC. $57.66 2023-2024 Teflaro
Mallinckrodt Enterprises LLC $52.95 2019
Itamar Medical INC $52.90 2024 Watchpatone
Abbott Laboratories $42.65 2021-2022
Viatris Specialty LLC $36.13 2025 Yupelri
Vanda Pharmaceuticals INC. $31.35 2021
Actelion Pharmaceuticals US, INC. $22.40 2024 Uptravi, Opsumit
Ethicon INC. $21.70 2024 Monarch Platform
Irhythm Technologies, INC. $20.75 2023 Zio Xt Patch
Phathom Pharmaceuticals, INC. $19.60 2024 Voquezna
Inspire Medical Systems, INC. $17.55 2023 Inspire
Advanced Respiratory, INC $17.36 2021
Merck Sharp & Dohme LLC $15.19 2021
Novo Nordisk INC $13.33 2020
Allergan, INC. $12.04 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert L Thomas

$13,156.43

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals Lp
Context
The $1,364 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/352074/robert-l-thomas

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.